MARKET

ABT

ABT

Abbott
NYSE

Real-time Quotes | Nasdaq Last Sale

121.38
-1.00
-0.82%
Opening 14:45 02/25 EST
OPEN
121.66
PREV CLOSE
122.38
HIGH
122.71
LOW
120.89
VOLUME
2.10M
TURNOVER
--
52 WEEK HIGH
128.54
52 WEEK LOW
61.61
MARKET CAP
215.03B
P/E (TTM)
48.26
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Cramer Gives His Opinion On Enphase Energy, Advanced Micro Devices, More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he really likes Enphase Energy Inc (NASDAQ: ENPH). It had a good quarter.
Benzinga · 2h ago
Nutritional and Dietary Supplements Market Research Report, Growth Trends and Competitive Analysis 2020-2027 |Ameco Research
pune, India, Thu, 25 Feb 2021 05:05:56 / Comserve Inc. / -- Nutritional supplements are any dietary supplement that is intended to provide nutrients that may...
Comserve · 9h ago
Stimulant-free Pre-workout Supplement Market Growth, Share, Trends and Forecasts 2020 to 2027 By Ameco Research
pune, India, Thu, 25 Feb 2021 05:05:28 / Comserve Inc. / -- The global Stimulant-free Pre-workout Supplement market is segmented by company, region...
Comserve · 9h ago
Global Irritable Bowel Syndrome with Constipation Drugs Market (2020 to 2028) - Players Include Abbott Laboratories, Astellas Pharma and Bayer Among Others - ResearchAndMarkets.com
BusinessWire - BZX · 9h ago
PC Compounding Market report (2021): Rising Demand,Extensive Growth and Strategies | Thorough augmentation up to 2030 [CAGR Of 4.30%]
Feb 25, 2021 (WiredRelease via Comtex) -- Marketresearch.biz has made significant efforts to analyze the PC Compounding industry’s accurate and useful data....
marketresearch.biz · 10h ago
1,4-Dichlorobenzene Market 2021 Research Revealing the Growth Rate and Business Opportunities to 2031
marketresearch.biz · 10h ago
Edible and Soluble Films Market Development Status (2022-2031), By Top-Vendor: Tsukioka Co. Ltd. and Watson Inc.
marketresearch.biz · 10h ago
Carton Display Market Growing Demand with Innovative Ideas Adopted by Key Players: Smurfit Kappa Group and Parkway Display
Feb 25, 2021 (WiredRelease via Comtex) -- A recent systematic review report on “Carton Display Market Business Advancements and Top-Vendor Landscape by 2031...
marketresearch.biz · 10h ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABT. Analyze the recent business situations of Abbott through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABT stock price target is 134.88 with a high estimate of 158.00 and a low estimate of 111.00.
EPS
Institutional Holdings
Institutions: 3.00K
Institutional Holdings: 1.39B
% Owned: 78.27%
Shares Outstanding: 1.77B
TypeInstitutionsShares
Increased
901
35.77M
New
283
316.82K
Decreased
891
38.76M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.80%
Healthcare Equipment & Supplies
-1.74%
Key Executives
Chairman/Executive Director
Miles White
President/Chief Executive Officer/Director
Robert Ford
Chief Financial Officer/Executive Vice President - Finance
Robert Funck
Executive Vice President/General Counsel/Secretary
Hubert Allen
Executive Vice President/Director of Human Resources
Mary Moreland
Executive Vice President
John Capek
Executive Vice President
Lisa Earnhardt
Executive Vice President
John Ginascol
Executive Vice President
Andrew Lane
Executive Vice President
Daniel Salvadori
Executive Vice President
Andrea Wainer
Senior Vice President
Roger Bird
Senior Vice President
Charles Brynelsen
Senior Vice President
Jaime Contreras
Senior Vice President
Michael Dale
Senior Vice President
Sammy Karam
Senior Vice President
Joseph Manning
Senior Vice President
Michael Pederson
Senior Vice President
Christopher Scoggins
Senior Vice President
Jared Watkin
Senior Vice President
Alejandro Wellisch
Senior Vice President
Randel Woodgrift
Lead Director/Independent Director
William Osborn
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
Sally Blount
Independent Director
Michelle Kumbier
Independent Director
Edward Liddy
Independent Director
Darren McDew
Independent Director
Nancy McKinstry
Independent Director
Nancy Mckinstry
Independent Director
Phebe Novakovic
Independent Director
Samuel Scott
Independent Director
Daniel Starks
Independent Director
John Stratton
Independent Director
Glenn Tilton
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
02/19/2021
Dividend USD 0.45
04/14/2021
12/11/2020
Dividend USD 0.45
01/14/2021
09/17/2020
Dividend USD 0.36
10/14/2020
06/12/2020
Dividend USD 0.36
07/14/2020
02/21/2020
Dividend USD 0.36
04/14/2020
12/13/2019
Dividend USD 0.36
01/14/2020
09/12/2019
Dividend USD 0.32
10/11/2019
06/14/2019
Dividend USD 0.32
07/12/2019
02/22/2019
Dividend USD 0.32
04/12/2019
12/14/2018
Dividend USD 0.32
01/14/2019
09/13/2018
Dividend USD 0.28
10/12/2018
06/08/2018
Dividend USD 0.28
07/12/2018
02/16/2018
Dividend USD 0.28
04/12/2018
12/15/2017
Dividend USD 0.28
01/11/2018
09/14/2017
Dividend USD 0.265
10/12/2017
06/09/2017
Dividend USD 0.265
07/12/2017
02/21/2017
Dividend USD 0.265
04/11/2017
12/12/2016
Dividend USD 0.265
01/11/2017
09/16/2016
Dividend USD 0.26
10/12/2016
06/10/2016
Dividend USD 0.26
07/13/2016
02/19/2016
Dividend USD 0.26
04/13/2016
12/11/2015
Dividend USD 0.26
01/13/2016
09/17/2015
Dividend USD 0.24
10/13/2015
06/12/2015
Dividend USD 0.24
07/13/2015
02/20/2015
Dividend USD 0.24
04/13/2015
02/11/2015
Dividend USD 0.24
01/13/2015
09/11/2014
Dividend USD 0.22
10/10/2014
06/13/2014
Dividend USD 0.22
07/11/2014
02/21/2014
Dividend USD 0.22
04/11/2014
10/16/2013
Dividend USD 0.22
01/13/2014
09/12/2013
Dividend USD 0.14
10/10/2013
06/14/2013
Dividend USD 0.14
07/11/2013
  • All
  • Financials
  • Insiders
More
About ABT
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.

Webull offers kinds of Abbott Laboratories stock information, including NYSE:ABT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABT stock methods without spending real money on the virtual paper trading platform.